Accuray (ARAY) Cash from Financing Activities (2010 - 2026)
Accuray (ARAY) reported Cash from Financing Activities of $4.1 million for Q1 2026, up 158.0% on a YoY basis from $1.6 million in Q1 2025, and up 1557.45% quarter-over-quarter from -$282000.0 in Q4 2025.
Accuray (ARAY) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Accuray has reported Cash from Financing Activities for 17 years, with the latest figure at $4.1 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 158.0% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 156.4% YoY), and the FY2025 full-year result was -$4.3 million, down 7.62% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $4.1 million, up from -$282000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $5.8 million in Q4 2024, with the low at -$15.5 million in Q1 2022.
- Historically, Cash from Financing Activities has averaged -$1.1 million across 5 years, with a median of -$475000.0 in 2025.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 336.5% — and 2024, when it surged 2343.58%.
- Accuray's Cash from Financing Activities stood at $4.3 million in 2022, then sank by 106.01% to -$257000.0 in 2023, then surged by 2343.58% to $5.8 million in 2024, then sank by 104.89% to -$282000.0 in 2025, then jumped by 1557.45% to $4.1 million in 2026.
- The last three Cash from Financing Activities figures came in at $4.1 million (Q1 2026), -$282000.0 (Q4 2025), and -$475000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | 4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.11 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | -282,000.00 |
| Dec 31, 2025 | -282,000.00 |
| Sep 30, 2025 | -475,000.00 |
| Sep 30, 2025 | -475,000.00 |
| Mar 31, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | -2.17 Mn |
| Sep 30, 2024 | -2.17 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Dec 31, 2023 | -257,000.00 |
| Dec 31, 2023 | -257,000.00 |
| Sep 30, 2023 | -1.50 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Mar 31, 2023 | -1.59 Mn |
| Mar 31, 2023 | -1.59 Mn |